Lexaria Bioscience Corp. featured in a Technical420 article praising the company’s recent developments Lexaria is improving and strengthening patent portfolio; 19 patent applications are pending in more than 40 countries Company executes partnership with NeutriSci International; joint venture allows LXRP to enter Asian market Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP), an innovative company licensing […]

Drug candidate for top cause of death in the United States Genetically-targeted therapy increases chances of recovery Interim efficacy analysis soon to be conducted by the Data Safety Monitoring Board Atrial fibrillation affects up to six million people in the U.S. The condition, if untreated, can lead to blood clots, stroke, heart failure and other […]

Proxy to shareholders seeks a reduction in Net Element’s common shares from 400 million to 100 million NETE reaches 30-month term stock purchase agreement with Cobblestone Partners Sets August 10 meeting with NASDAQ to present plan for listing compliance Net Element, Inc. (NASDAQ: NETE) has proposed to shareholders a reverse split of its common stock […]

Fundamental value drivers of InMed Pharmaceuticals are its drug development pipeline and proprietary biosynthesis technology in cannabinoid manufacturing Biopharmaceutical company already has two drug candidates – INM-085 and INM-750 – in the multi-billion dollar ocular and dermatology markets INM-085 and INM-750 target markets valued in excess of $5 billion and $1 billion, respectively InMed Pharmaceuticals, […]

New Chinese economy has produced new Chinese consumer Consumer has pent up demand Moxian provides platform to motivate and move consumers to retail outlets There’s little doubt that economic forces have transformed the Chinese consumer markets. The meteoric rise of middle-class households, a new generation of tech savvy consumers and the powerful pull of e-commerce […]

NASDAQ Biotechnology Index up and climbing Developing new treatment for acute myeloid leukemia (AML) Lead candidate, Annamycin, now at phase II Since a rising sea lifts all boats, it’s decidedly good news for Moleculin Biotech, Inc. (NASDAQ: MBRX) that the NASDAQ Biotechnology Index (NBI) is enjoying a spring tide. The index has offered a year-to-date […]

Millions of Americans live in areas with little or no comprehensive health care MIHI establishing nationwide telemedicine network to provide specialty care Serving the underserved makes MIHI sole practitioner to millions There’s no doubt that the U.S. health care system is fractured. Our patchwork quilt of health care services leaves many citizens isolated and medically […]

Huge and exponentially growing global need Industry independent Established reputation for reliability and cost-effectiveness If there’s one challenge that dominates almost every aspect of our modern information age, it is most certainly Big Data. Over and above the increasing number of ways Big Data can be processed and analyzed, depending upon the need, the most […]

IGC purchased exclusive rights to USF patent focused on preventing amyloid-beta plaques from aggregating on neurons Company plans to pursue clinical trials related to this patent on path to FDA approval In 2017, direct costs associated with Alzheimer’s and other dementias will total an estimated $259 billion, according to the Alzheimer’s Association If you are […]

Origo to acquire High Times in transaction valued at $250 million High Times will be traded under Origo’s ticker symbol following close of acquisition Better access to capital and an elevated profile will enable High Times to expand its brand and fund new opportunities Origo Acquisition Corp. (NASDAQ: OACQ) is acquiring the iconic marijuana media […]